Bcl-X(L) expression and its downregulation by a novel retinoid in breast carcinoma cells.
Bcl-X(L) expression and its downregulation by a novel retinoid in breast carcinoma cells.
复制标题
乳腺癌细胞中 Bcl-X(L) 的表达及其通过新型视黄醇的下调。
DOI:
10.1006/excr.1997.3509
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Fontana,JA
中科院分区:
文献类型:
--
作者:
Hsu,CK;Rishi,AK;Li,XS;Dawson,MI;Reichert,U;Shroot,B;Fontana,JA
We have recently found a novel retinoid, 6-[3-(1-adamantyl)-4-hydroxphenyl]-2-naphthalenecarboxylic acid (CD437), which induces G1cell cycle arrest and apoptosis in human breast carcinoma (HBC) cells (Oncogene11, 493–504, 1995). CD437 downregulates the expression of a number of proteins which antagonize apoptosis. bcl-XL, a homologue of bcl-2, antagonizes apoptosis, while bcl-XSenhances apoptosis. We have found that estrogen receptor (ER)-negative HBCs express higher levels of bcl-XLand significantly lower levels of bcl-2 than their ER-positive counterparts. Neither cell type expresses bcl-XS. The addition of CD437 (1 μM) results in a fourfold downregulation of bcl-XLmRNA and protein levels followed by apoptosis in MDA-MB-231 and MDA-MB-468 cells. CD437 concentrations as low as 10 nMcause a significant reduction in both bcl-X mRNA and bcl-XLprotein expression. CD437-dependent downregulation of bcl-X mRNA and bcl-XLprotein expression occurs within 24 h of CD437 addition to the cells. Retinoic acid does not effect bcl-X mRNA or bcl-XLprotein expression. CD437 is a potent inducer of apoptosis in a number of breast carcinoma cells lines and downregulates the expression of a number of proteins which antagonize apoptosis.